Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> ABBVIE Latest News

5 HOURS AGO - Chicago Tribune

A Must Read - Share

AbbVie closes $21 billion deal for Pharmacyclics

AbbVie said Tuesday that it has completed its $21 billion acquisition of Pharmacyclics, giving the North Chicago-based company a presence in the multibillion-dollar market for treating blood cancers.

Tags: AbbVie closes $21 billion deal for Pharmacyclics,  Abbvie Latest News

10 HOURS AGO - TheStreet

A Must Read - Share

AbbVie (ABBV) Stock Gains After Completing $21 Billion Pharmacyclics Purchase

NEW YORK (TheStreet) -- AbbVie shares are up 1.99% to $66.78 in afternoon trading on Tuesday after the pharmaceutical company completed its $21 billion buyout of Pharmacyclics  .The deal will add Pharmacyclics' blood cancer treatment Imbruvica to Abbvie's drug portfolio which already features the world's top selling drug Humira. The closing of the deal comes after the company ended its $55 billion tax ...

Tags: AbbVie (ABBV) Stock Gains After Completing $21 Billion Pharmacyclics Purchase,  Abbvie Latest News

11 HOURS AGO - Benzinga

A Must Read - Share

AbbVie Makes SEC Filings Relating To Its Previously Announced Agreement and Plan of Reorganization with Pharmacyclics, Inc.

AbbVie Inc. ("AbbVie") (NYSE / CHX / Euronext Paris / SIX: ABBV) today informs its stockholders that it has filed an amendment to its tender offer statement on Schedule TO and a Current Report on Form 8-K with the U.S. Securities and Exchange Commission ("SEC") relating to its previously announced agreement and plan of reorganization with Pharmacyclics, Inc.

Tags: AbbVie Makes SEC Filings Relating To Its Previously Announced Agreement and Plan of Reorganization with Pharmacyclics, Inc.,  Abbvie Latest News

MAY 22, 2015 - TheStreet

A Must Read - Share

5 Investments That Show John Paulson Knows How to Play M&A

NEW YORK (TheStreet) -- John Paulson said in a 2014 interview that he expected high levels of corporate merger and acquisition activity to continue "for the foreseeable future." He has stacked his chips accordingly, and it is paying off. The Paulson Enhanced fund, which bets on mergers and acquisitions, climbed more than 13% during the first quarter of the year, according to ...

Tags: 5 Investments That Show John Paulson Knows How to Play M&A,  Abbvie Latest News

MAY 22, 2015 - Benzinga

A Must Read - Share

AbbVie Announces Expiration of Hart-Scott-Rodino Waiting Period for AbbVie's Acquisition of Pharmacyclics

AbbVie (NYSE: ABBV) announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for AbbVie's purchase of Pharmacyclics, Inc. has expired today.

Tags: AbbVie Announces Expiration of Hart-Scott-Rodino Waiting Period for AbbVie's Acquisition of Pharmacyclics,  Abbvie Latest News